NuSkin Enterprises, Inc. (NUS) Stock Price

NUSStock

$5.14−51.78%52W

Market Cap$250.20M

P/E1.56x

PEG Ratio0.78

Div yield9.03%

Beta0.95

NUS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-43.50%

Price vs S&P 500 (4W)11.15%

PEG Ratio0.78

VGM Score46.34

P/E Ratio (Annual)1.56x

Indicated Dividend Yield (Annual)9.03%

P/CF (Annual)3.12x

Book Value / Share (Quarterly)$11.14

P/TBV (Annual)0.61x

Indicated Dividend (Annual)$0.24

Revenue Growth (3Y)-12.62%

Cash Flow / Share (Quarterly)$0.22

Payout Ratio (TTM)21.47%

Price vs S&P 500 (YTD)-58.50%

Gross Margin (TTM)69.19%

Net Profit Margin (TTM)-15.73%

EPS (TTM)$-4.48

10-Day Avg Trading Volume0.48M

EPS Excl Extra (TTM)$-4.48

Revenue Growth (5Y)-10.47%

EPS (Annual)$3.18

Dividend / Share (Annual)$0.24

ROI (Annual)15.47%

Gross Margin (Annual)69.45%

Net Profit Margin (5Y Avg)2.59%

Cash / Share (Quarterly)$3.93

P/E Basic Excl Extra (TTM)4.30x

Revenue Growth QoQ (YoY)-17.10%

EPS Growth (5Y)-2.56%

P/E Normalized (Annual)1.56x

ROA (Last FY)11.40%

Revenue Growth TTM (YoY)-15.44%

EBITD / Share (TTM)$0.80

ROE (5Y Avg)5.25%

Operating Margin (TTM)-0.76%

Cash Flow / Share (Annual)$0.95

P/B Ratio0.46x

P/B Ratio (Quarterly)0.47x

Net Income / Employee (Annual)$57,200

EV / Revenue (TTM)0.20x

Net Interest Coverage (TTM)5.67x

ROA (TTM)-16.25%

EPS Growth QoQ (YoY)-98.26%

EV / EBITDA (TTM)6.93x

EPS Incl Extra (Annual)$3.18

Current Ratio (Annual)2.08x

Quick Ratio (Quarterly)0.94x

3-Month Avg Trading Volume0.62M

52-Week Price Return-51.78%

EV / Free Cash Flow (Annual)5.96x

P/E Incl Extra (TTM)4.30x

Revenue / Employee (TTM)$491,200

Tangible BV / Share (Quarterly)$10.37

P/S Ratio (Annual)0.17x

Asset Turnover (Annual)1.06x

52-Week High$11.67

Operating Margin (5Y Avg)4.73%

EPS Excl Extra (Annual)$3.18

CapEx CAGR (5Y)-11.68%

Tangible BV CAGR (5Y)-1.07%

26-Week Price Return-33.59%

Quick Ratio (Annual)1.14x

13-Week Price Return-1.91%

Total Debt / Equity (Annual)0.29x

Current Ratio (Quarterly)1.98x

Enterprise Value$274.22M

Revenue / Share Growth (5Y)-9.60%

Asset Turnover (TTM)1.03x

Book Value / Share Growth (5Y)-1.00%

Revenue / Employee (Annual)$530,400

Inventory Turnover (Annual)2.46x

Pretax Margin (Annual)13.21%

Cash / Share (Annual)$5.02

3-Month Return Std Dev37.27%

Gross Margin (5Y Avg)70.64%

Net Income / Employee (TTM)$-77,300

EBITDA CAGR (5Y)-2.37%

EBITDA Interim CAGR (5Y)-27.41%

ROE (Last FY)19.90%

Net Interest Coverage (Annual)-0.68x

EPS Basic Excl Extra (Annual)$3.18

P/FCF (TTM)8.81x

Receivables Turnover (TTM)25.33x

EV / Free Cash Flow (TTM)25.44x

Total Debt / Equity (Quarterly)0.39x

EPS Incl Extra (TTM)$-4.48

Receivables Turnover (Annual)32.88x

ROI (TTM)-22.59%

Dividend Growth Rate (5Y)-30.34%

P/S Ratio (TTM)0.18x

Pretax Margin (5Y Avg)3.41%

Revenue / Share (Annual)$29.53

Tangible BV / Share (Annual)$15.82

Forward P/E4.66x

Free OCF CAGR (5Y)-31.95%

Price vs S&P 500 (52W)-67.31%

P/E Ratio (TTM)4.30x

Year-to-Date Return-46.57%

5-Day Price Return5.54%

EPS Normalized (Annual)$3.18

ROA (5Y Avg)3.08%

Net Profit Margin (Annual)10.79%

Month-to-Date Return13.47%

Cash Flow / Share (TTM)$2.60

EBITD / Share (Annual)$5.85

EPS Growth (3Y)15.35%

Operating Margin (Annual)16.29%

LT Debt / Equity (Annual)0.25x

P/CF (TTM)4.92x

ROI (5Y Avg)4.31%

P/E Excl Extra (TTM)4.30x

LT Debt / Equity (Quarterly)0.36x

EPS Basic Excl Extra (TTM)$-4.48

P/TBV (Quarterly)0.51x

Payout Ratio (Annual)7.39%

P/B Ratio (Annual)0.58x

Dividend / Share (TTM)$0.24

Inventory Turnover (TTM)2.28x

Pretax Margin (TTM)-1.92%

Book Value / Share (Annual)$16.71

Price vs S&P 500 (13W)-4.59%

Net Margin Growth (5Y)7.81%

Dividend Yield (TTM)4.66%

Beta0.95x

P/FCF (Annual)5.44x

Revenue / Share (TTM)$28.30

ROE (TTM)-29.42%

52-Week Low$4.45

vGradeB

gGradeF

mGradeC

vgmGradeC

NUS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	$0.20	$0.20	+0.00%(+$0.00)
Q1 2026	May 7, 2026	$0.15	$0.14	-6.67%(-$0.01)
Q4 2025	Feb 12, 2026	$0.30	$0.29	-3.33%(-$0.01)
Q3 2025	Nov 6, 2025	$0.30	$0.34	+13.33%(+$0.04)
Q2 2025	Aug 7, 2025	—	$0.43	—

NUS Analyst Recommendations

Mar 2025

Apr 2025

May 2025

Jun 2025

2.33

2.25

Industry Peers — Drug Wholesale(11)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
NUSNuSkin Enterprises, Inc.	B	F	C	1.6x	-29.4%	-0.8%	-15.4%	$5.14
MCKMcKesson Corporation	D	B	B	24.6x	39.4%	1.6%	8.8%	$1004.84
CORCencora, Inc.	D	B	B	41.9x	106.4%	0.9%	5.1%	$340.92
CAHCardinal Health, Inc.	D	B	A	34.3x	37.2%	1.0%	14.2%	$254.06
HLFHerbalife Ltd.	B	D	A	6.7x	170.7%	-14.1%	5.5%	$14.60
WGRXWellgistics Health, Inc. Common Stock	D	F	D	—	-1645.9%	-506.9%	-51.6%	$4.28
ZSTKZeroStack Corp. Common Stock	—	D	C	—	-382.3%	-595.2%	—	$4.00
ESYNEnerSyn Global Inc. Common Stock	—	—	C	—	—	—	—	$1.94
COSMCosmos Holdings Inc. Common Stock	D	B	C	—	-118.9%	-24.8%	33.8%	$0.33
HWHHWH International Inc. Common Stock	F	D	B	—	-103.9%	-716.1%	-68.5%	$1.98
MEDSDataMeds AI, Inc. Common Stock	D	D	D	—	-1645.9%	-1034.0%	-78.2%	$2.63
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares	—	F	F	—	—	—	—	$0.11

About NuSkin Enterprises, Inc.

Nu Skin Enterprises develops and distributes beauty and wellness products globally through its Nu Skin brand and Rhyz subsidiary. The company operates across multiple geographic markets, with the Americas segment generating the majority of revenue, particularly from wellness products. Rhyz manages the company's manufacturing operations and strategic investments.